Follicular Lymphoma Treatment in India
- Top Accredited Hospitals
- Global Medical Standards
- Cutting-Edge Technology
- Proven Treatment Options
- High Success Rate
- Trusted by Millions
What is a Follicular Lymphoma?
Follicular lymphoma is a type of B-cell non-Hodgkin lymphoma that develops from abnormal B lymphocytes, a type of white blood cell involved in the immune system. It is generally considered an indolent, or slow-growing, lymphoma, although its behaviour can vary between individuals. Follicular lymphoma commonly affects lymph nodes but can also involve the bone marrow, spleen, and other tissues.
What is the Importance of Timely Treatment?
Timely diagnosis and appropriate management can help determine the extent and biological characteristics of follicular lymphoma and guide treatment decisions. Because many cases grow slowly, immediate treatment is not always necessary. Some patients with asymptomatic, low-burden disease may be monitored through active surveillance, or watchful waiting.
What are the Common Symptoms of Follicular Lymphoma?
- Painless swelling of lymph nodes in the neck, armpit, or groin
- Persistent fatigue or weakness
- Unexplained weight loss
- Fever without an obvious infection
- Drenching night sweats
- Abdominal discomfort or fullness due to an enlarged spleen or lymph nodes
- Recurrent infections in some patients
- Shortness of breath or other symptoms when enlarged lymph nodes affect nearby structures
Causes and Risk Factors of Follicular Lymphoma
Causes
- The exact cause of follicular lymphoma is not fully understood. It develops when genetic changes occur in B lymphocytes, causing them to grow or survive abnormally.
- A characteristic genetic change involving the BCL2 gene on chromosome 18 is commonly associated with follicular lymphoma, although this change alone does not necessarily cause lymphoma.
Risk Factors
- Increasing age
- Certain abnormalities of the immune system
- Immunosuppressive conditions or treatments
- Some autoimmune diseases
- Certain infections or environmental exposures may be associated with lymphoma risk, although their specific role in follicular lymphoma varies
Latest Research and Technologies in the Treatment of Follicular Lymphoma in India
- Treatment of follicular lymphoma has evolved with advances in immunotherapy, targeted therapy, cellular therapy, and molecular diagnostics. Monoclonal antibodies targeting CD20 remain important treatment options. Targeted medicines such as selected PI3K-pathway therapies may be used in specific settings. For patients with relapsed or refractory disease, newer approaches include bispecific antibodies and CAR-T cell therapy, depending on disease characteristics, previous treatments, regulatory approvals, and patient eligibility.
Treatment options for Follicular Lymphoma
Immunotherapy : Anti-CD20 antibodies such as rituximab or obinutuzumab may be used alone or in combination with other treatments.
Cost Start From 1500Explore Options
Chemoimmunotherapy: Chemotherapy combined with an antibody may be considered for patients who require systemic treatment.
Targeted therapy : Targeted medicines may be considered in selected relapsed or refractory cases.
Cost Start From 1000Explore Options
CAR-T cell therapy : For selected patients with relapsed or refractory follicular lymphoma after previous systemic treatments, CAR-T therapy may be considered at specialised centres.
Cost Start From 80000Explore Options
Stem cell transplantation : Autologous stem cell transplantation may be considered in selected patients with relapsed or refractory disease, although its use depends on the clinical situation and availability of newer therapies.
Cost Start From 11500Explore Options
Clinical assessment:
- Detailed medical history and physical examination, including assessment of enlarged lymph nodes, spleen, and other symptoms. Blood tests may evaluate blood cell counts, kidney and liver function, and other relevant markers.
- Tissue biopsy: An excisional or core lymph-node biopsy is generally important to confirm the diagnosis and determine the lymphoma subtype and grade. Immunohistochemistry and other pathological tests help identify characteristic markers.
- Bone marrow evaluation: Bone marrow testing may be considered in selected patients depending on the clinical situation and whether the results will influence staging or treatment.
Imaging Tests:
- PET/CT scan: Helps identify metabolically active lymphoma and assess disease distribution and treatment response.
- CT scan: Can evaluate enlarged lymph nodes and involvement of organs such as the chest, abdomen, and pelvis.
- MRI: May be used when detailed assessment of particular organs or anatomical areas is required.
- Ultrasound: Can help evaluate superficial lymph nodes or abdominal organs in selected cases.
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services designed to support Follicular Lymphoma patients in India. These services include:
- Physical activity: Gradual activity can help maintain strength and endurance.
- Physiotherapy: May help with weakness, reduced mobility, or treatment-related physical limitations.
- Nutritional support: Helps maintain adequate calorie and protein intake during treatment.
- Fatigue management: Structured activity, rest, sleep support, and energy conservation strategies can help manage cancer-related fatigue.
- Psychological support: Counselling and supportive-care services may help patients cope with the emotional impact of diagnosis and treatment.
- Medicines used for follicular lymphoma depend on whether the disease is newly diagnosed, symptomatic, relapsed, or refractory. Treatment may include anti-CD20 monoclonal antibodies, chemotherapy, immunomodulatory medicines, targeted therapies, and newer immune-based treatments such as bispecific antibodies. The choice depends on disease characteristics, previous therapies, treatment response, and the patient's overall health.
Instantly Connect with our Specialists
Hospitals for Follicular Lymphoma in India
Apollo Hospital
Chennai, India
Apollo Hospital located in Chennai, India is accredited by JCI, NABH. Also listed below are some of the most prominent infrastructural details:
- Committed Centers of Excellence involving many major specialties, super specialties
- Assistance in trip planning and execution
- Insurance related assistance
- Visa facilitation
- International patient representatives for complete end to end travel and transfer processing for medical travellers
- Language translators availability
- Robust safety and infection protocols
- Personalised, Visa and Premium Health Checks available
- Health Library and accessing health records online
- Wide variety of procedures accomplished including complex and critical procedures
- Technologically advanced systems and procedures in place
- Research and academics base of healthcare delivery
Apollo Multispecialty Hospitals
Kolkata, India
Apollo Multispecialty Hospitals located in Kolkata, India is accredited by JCI, NABH. Also listed below are some of the most prominent infrastructural details:
- International patient Center
- Focus on research and innovation
- Different amenities: Transport, Security, Travel Desk, Places of Worship, Telecommunication Service, Special Nurse, Food & Dietary Services
- Several kinds of rooms: General ward, Semi Private Rooms, Private Rooms, Deluxe, Super Deluxe, Suite, Maharaja Suite, HDU, Gastro ICU, Emergency, Neonatal ICU, Level 1, Level 2 & Level 3
- Health Insurance coverage available
- Here is a comprehensive list of the various kinds of key medical procedures performed through the latest technology.
- Arthroscopy
- Bone Marrow Transplant
- Cosmetic Surgery
- Da Vinci Robotic Surgical System
- Fractional Flow Reserve (FFR)
- Hand Microsurgery
- Hip Arthroscopy
- Minimally Invasive Cardiac Surgery
- Minimally Invasive Subvastus Total Knee Replacement
- Oral & Maxillofacial Surgery
- 128 Slice PET CT
- Bioresorbable Vascular Scaffold (BVS)
- ECMO
- OCT Technique - Optical Coherence Tomography
- Single Port Endoscopic technique of Carpal Tunnel Release (ECTR)
Indraprastha Apollo Hospital
Delhi, India
Indraprastha Apollo Hospital is known for delivering treatment to over 200,000 patients every year; 10,000 of which are generally medical tourists. The efficient team of doctors has the record of 99.6 percent success rate. Indraprastha Apollo Hospital deals in treatment of over 50 specialities.
Let’s see some of the features of the infrastructure:
- Spread over 15 acres, the hospital has 710 beds.
- 6 beds dedicated to bone marrow transplant units with very strict infection control practices.
- 64-Slice Scan coupled with data acquisition which provides highest temporal resolution
- One of the hospitals to be using Da Vinci Robotics Surgery System
- In South Asia, the Spect-CT and Pet-CT got their first installation at Indraprastha Apollo Hospital in India
- Technologies such as PET- MR, BrainLab Navigation System, PET-CT, Portable CT Scanner, Tilting MRI, NovalisTx, Cobalt based HDR Brachytherapy, Hyperbaric Chamber, DSA Lab, Fibroscan, 3 Tesla MRI, Endosonography, 128 Slice CT scanner are all installed at the hospital.
- The Cancer Institute at Indraprastha Apollo is equipped with a highly advanced Radiation Oncology Center with ClinaciX, NovalisTx, and HDR-Brachytherapy.
- It is equipped with the largest Sleep Lab in Asia, & has one of the largest Dialysis Units in India.
- A large number of ICU beds than any other Private Hospitals in India.
- WIFI is accessible across the whole campus.
Our Services to better your experience
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Why Choose India for Follicular Lymphoma Treatment?
- Experienced hematologist-oncologists: Specialists experienced in lymphoma diagnosis, systemic therapy, and long-term disease management.
- Advanced diagnostic facilities: PET/CT, immunohistochemistry, flow cytometry, cytogenetic and molecular testing can support accurate diagnosis and treatment planning.
- Modern treatment options: Eligible patients may have access to immunotherapy, targeted treatments, bispecific antibodies, and cellular therapies at specialised centres.
- Multidisciplinary care: Haematologists, oncologists, pathologists, radiologists, radiation oncologists, transplant specialists, and supportive-care teams can collaborate on complex cases.
- International patient support: Many hospitals have dedicated international patient services that can assist with medical coordination, documentation, accommodation, travel-related arrangements, and follow-up planning.
Frequently Asked Questions
There is no fixed recovery period because follicular lymphoma is usually a chronic condition that may require long-term monitoring or treatment. Recovery after active treatment depends on the therapy used, disease response, side effects, and overall health.
Yes. Most people with follicular lymphoma can walk and stay physically active, especially when the disease isn't causing significant physical limitations. During treatment, you may need to adjust activity levels based on fatigue, blood counts, treatment effects, and medical advice.
Many specialised Indian cancer centres have access to advanced diagnostic and treatment technologies, including PET/CT, immunohistochemistry, molecular testing, immunotherapy, targeted therapies, and cellular therapies. Availability varies by hospital and by individual patient eligibility.
Many major Indian hospitals have dedicated international patient departments that assist with medical appointments, treatment coordination, travel documentation, accommodation, interpretation, and follow-up arrangements.
Consider a centre with experienced hematologist-oncologists, specialised lymphoma services, advanced pathology and imaging, access to appropriate systemic therapies, and multidisciplinary care. For relapsed or refractory disease, patients may also consider whether the centre provides cellular therapies such as CAR-T when clinically appropriate.
There is no single success rate for follicular lymphoma. Outcomes vary by stage, tumour burden, disease biology, age, overall health, treatment received, and response to therapy. Follicular lymphoma is often responsive to treatment, but it can relapse and may require long-term monitoring.
India has specialised hematology and oncology centres with doctors experienced in diagnosing and treating non-Hodgkin lymphomas, including follicular lymphoma. Experience and available treatments vary between institutions, so patients should review the specialist's lymphoma expertise and the hospital's treatment facilities.
Risks depend on the treatment used. Chemotherapy may cause fatigue, nausea, hair loss, low blood counts, and increased infection risk. Immunotherapy and targeted treatments can cause infusion reactions, immune-related effects, or other treatment-specific adverse effects. CAR-T therapy can cause complications such as cytokine release syndrome and neurological toxicities in some patients.
After diagnosis, consult a hematologist-oncologist to confirm the lymphoma subtype, grade, and stage and discuss whether immediate treatment or active surveillance is appropriate. Ask about the biopsy results, imaging findings, treatment options, expected benefits and risks, and whether a second pathology or specialist opinion is appropriate.
Follicular lymphoma does not typically cause permanent physical deformities. However, advanced disease or treatment-related complications can sometimes affect physical function, depending on which organs or tissues are involved.
Yes. Symptoms such as fatigue, enlarged lymph nodes, night sweats, emotional stress, and treatment-related side effects can affect physical, social, and emotional well-being. Supportive care, symptom management, physical activity, nutrition, and psychological support can help address these concerns.
Some follicular lymphomas can remain stable for years without immediate treatment, so active surveillance may be appropriate for selected patients. However, progressive disease can eventually cause symptoms, organ involvement, or complications. Rarely, follicular lymphoma can transform into a more aggressive form of lymphoma.
There is no established way to completely prevent follicular lymphoma because its exact cause is unknown. Maintaining overall health, avoiding tobacco exposure, following appropriate medical care for immune-related conditions, and discussing persistent or unexplained symptoms with a healthcare professional can support general health but cannot guarantee prevention.
Follicular lymphoma is more common in adults, particularly older adults, and occurs more frequently in some populations than others. The risk can also be influenced by immune-system disorders and certain other factors. Most people with these risk factors do not necessarily develop follicular lymphoma.